Cargando…

Predicting clinically significant prostate cancer using DCE-MRI habitat descriptors

Prostate cancer diagnosis and treatment continues to be a major public health challenge. The heterogeneity of the disease is one of the major factors leading to imprecise diagnosis and suboptimal disease management. The improved resolution of functional multi-parametric magnetic resonance imaging (m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parra, Andres N., Lu, Hong, Li, Qian, Stoyanova, Radka, Pollack, Alan, Punnen, Sanoj, Choi, Jung, Abdalah, Mahmoud, Lopez, Christopher, Gage, Kenneth, Park, Jong Y., Kosj, Yamoah, Pow-Sang, Julio M., Gillies, Robert J., Balagurunathan, Yoganand
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324677/ https://www.ncbi.nlm.nih.gov/pubmed/30647849 http://dx.doi.org/10.18632/oncotarget.26437

Ejemplares similares

Erratum: Predicting clinically significant prostate cancer using DCE-MRI habitat descriptors
por: Parra, N. Andres, et al.
Publicado: (2019)

Habitats in DCE-MRI to Predict Clinically Significant Prostate Cancers
por: Parra, Nestor Andres, et al.
Publicado: (2019)

Automatic Detection and Quantitative DCE-MRI Scoring of Prostate Cancer Aggressiveness
por: Parra, Nestor Andres, et al.
Publicado: (2017)

Classifying Malignancy in Prostate Glandular Structures from Biopsy Scans with Deep Learning
por: Fogarty, Ryan, et al.
Publicado: (2023)

Delineation of Tumor Habitats based on Dynamic Contrast Enhanced MRI
por: Chang, Yu-Cherng Channing, et al.
Publicado: (2017)

Automatic Detection of Prostate Tumor Habitats using Diffusion MRI
por: Tschudi, Yohann, et al.
Publicado: (2018)

Multiparametric-MRI and Targeted Biopsies in the Management of Prostate Cancer Patients on Active Surveillance
por: Sandler, Kiri, et al.
Publicado: (2015)

Radiological semantics discriminate clinically significant grade prostate cancer
por: Li, Qian, et al.
Publicado: (2019)

Repeatability of Quantitative Imaging Features in Prostate Magnetic Resonance Imaging
por: Lu, Hong, et al.
Publicado: (2020)

In Vivo Imaging of Rat Vascularity with FDG-Labeled Erythrocytes
por: Wang, Shaowei, et al.
Publicado: (2022)

Optimizing patient's selection for prostate biopsy: A single institution experience with multi-parametric MRI and the 4Kscore test for the detection of aggressive prostate cancer
por: Punnen, Sanoj, et al.
Publicado: (2018)

Association of multiparametric MRI quantitative imaging features with prostate cancer gene expression in MRI-targeted prostate biopsies
por: Stoyanova, Radka, et al.
Publicado: (2016)

Entering an era of radiogenomics in prostate cancer risk stratification
por: Soodana-Prakash, Nachiketh, et al.
Publicado: (2018)

Multi-window CT based Radiomic signatures in differentiating indolent versus aggressive lung cancers in the National Lung Screening Trial: a retrospective study
por: Lu, Hong, et al.
Publicado: (2019)

Longitudinal Changes and Predictive Value of Multiparametric MRI Features for Prostate Cancer Patients Treated with MRI-Guided Lattice Extreme Ablative Dose (LEAD) Boost Radiotherapy
por: Algohary, Ahmad, et al.
Publicado: (2022)

Quantitative Computed Tomographic Descriptors Associate Tumor Shape Complexity and Intratumor Heterogeneity with Prognosis in Lung Adenocarcinoma
por: Grove, Olya, et al.
Publicado: (2015)

Phase I dose escalation trial of stereotactic radiotherapy prior to robotic prostatectomy in high risk prostate cancer
por: Liveringhouse, Casey, et al.
Publicado: (2021)

Correction: Quantitative Computed Tomographic Descriptors Associate Tumor Shape Complexity and Intratumor Heterogeneity with Prognosis in Lung Adenocarcinoma
por: Grove, Olya, et al.
Publicado: (2021)

Clinical-Genomic Risk Group Classification of Suspicious Lesions on Prostate Multiparametric-MRI
por: Stoyanova, Radka, et al.
Publicado: (2023)

African‐American men and prostate cancer‐specific mortality: a competing risk analysis of a large institutional cohort, 1989–2015
por: Williams, Vonetta L., et al.
Publicado: (2018)

Quantitative Imaging features Improve Discrimination of Malignancy in Pulmonary nodules
por: Balagurunathan, Yoganand, et al.
Publicado: (2019)

Comparison of Ultrafast Dynamic Contrast-Enhanced (DCE) MRI with Conventional DCE MRI in the Morphological Assessment of Malignant Breast Lesions
por: Ohashi, Akane, et al.
Publicado: (2023)

Breast MR with special focus on DW-MRI and DCE-MRI
por: Petralia, G., et al.
Publicado: (2011)

DCE-MRI and DWI Integration for Breast Lesions Assessment and Heterogeneity Quantification
por: Méndez, C. Andrés, et al.
Publicado: (2012)

Generative Adversarial Networks Can Create High Quality Artificial Prostate Cancer Magnetic Resonance Images
por: Xu, Isaac R. L., et al.
Publicado: (2023)

Validation of a deformable MRI to CT registration algorithm employing same day planning MRI for surrogate analysis
por: Padgett, Kyle R., et al.
Publicado: (2018)

Assessment of cardiac RF ablation lesions by DCE-MRI
por: Vijayakumar, Sathya, et al.
Publicado: (2014)

Dependence of DCE-MRI biomarker values on analysis algorithm
por: Ng, Chaan S., et al.
Publicado: (2015)

DCE-MRI of Tumor Hypoxia and Hypoxia-Associated Aggressiveness
por: Gaustad, Jon-Vidar, et al.
Publicado: (2020)

Editorial: Use of DCE-MRI in female affecting cancers
por: Romeo, Valeria, et al.
Publicado: (2023)

Proton beam therapy: clinical utility and current status in prostate cancer
por: Yamoah, Kosj, et al.
Publicado: (2016)

Integration of DCE-MRI and DW-MRI Quantitative Parameters for Breast Lesion Classification
por: Fusco, Roberta, et al.
Publicado: (2015)

Divorcing Diagnosis From Treatment: Contemporary Management of Low-Risk Prostate Cancer
por: Glass, Allison S., et al.
Publicado: (2013)

A Gradient-Based Approach for Breast DCE-MRI Analysis
por: Losurdo, L., et al.
Publicado: (2018)

Differentiation of Myositis-Induced Models of Bacterial Infection and Inflammation with T(2)-Weighted, CEST, and DCE-MRI
por: Goldenberg, Joshua M., et al.
Publicado: (2019)

Intermittent Hypoxia Selects for Genotypes and Phenotypes That Increase Survival, Invasion, and Therapy Resistance
por: Verduzco, Daniel, et al.
Publicado: (2015)

Understanding DCE /
por: Rosenberry, Ward
Publicado: (1992)

DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents
por: O'Connor, J P B, et al.
Publicado: (2007)

Assessment of gadoxetate DCE-MRI as a biomarker of hepatobiliary transporter inhibition
por: Ulloa, Jose L, et al.
Publicado: (2013)

Renal DCE-MRI Model Selection Using Bayesian Probability Theory
por: Beeman, Scott C., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_lf069vgi7gk09t66pnup913om2